Oct 17, 2022
Cancer vaccine could be ready for use by 2030, say BioNTech founders
Posted by Gemechu Taye in category: biotech/medical
Lessons from COVID vaccine development and approval can aid the process.
According to Uğur Şahin and Özlem Türeci, the founders of the German company BioNTech, mRNA vaccines that can help target cancer could be ready for use before the end of this decade, The Guardian.
Wildpixel/iStock.
Continue reading “Cancer vaccine could be ready for use by 2030, say BioNTech founders” »